Study on the Body Mass Balance and Biotransformation of [14C]-HEC585
Clinical trial NCT05468346 · COMPLETED
Trial details
- NCT number
- NCT05468346
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-26
- Primary completion
- 2022-08-14
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.